Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-01-01 @ 12:23 AM
Study NCT ID:
NCT04925856
Status:
RECRUITING
Last Update Posted:
2023-10-17
First Post:
2021-06-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
Sponsor:
Centre Georges Francois Leclerc
Organization:
Study Overview
Official Title:
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMMUNE CAPTURE
Brief Summary:
This study aims to constitute a most complete biological collection for patients treated for localized or metastatic breast cancer (in different cohorts depending on the type of systemic treatment received), in order to describe the basal immune response of patients treated for a breast cancer according to the stage of the disease, but above all to study how the different systemic treatments used in the management of breast cancer modulate this immune response.
Detailed Description:
The main objective of this study is to describe, depending on the type of systemic treatment received, the blood immune response before treatment and its evolution under treatment.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: